Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424. https://doi.org/10.3322/caac.21492

Article  PubMed  Google Scholar 

Gao K, Wu J (2019) National trend of gastric cancer mortality in China (2003–2015): a population-based study. Cancer Commun (Lond) 39(1):24. https://doi.org/10.1186/s40880-019-0372-x

Article  PubMed  Google Scholar 

Bang YJ, Kim YW, Yang HK et al (2012) Adjustment capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet 379(9813):315–321. https://doi.org/10.1016/S0140-6736(11)61873-4

Article  CAS  PubMed  Google Scholar 

Association JGC (2017) Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer 20(1):1–19. https://doi.org/10.1007/s10120-016-0622-4

Article  Google Scholar 

Sakuramoto S, Sasako M, Yamaguchi T et al (2007) Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 357:1810–1820. https://doi.org/10.1056/NEJMoa072252

Article  CAS  PubMed  Google Scholar 

Sasako M, Sakuramoto S, Katai H et al (2011) Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J Clin Oncol 29:4387–4393. https://doi.org/10.1200/JCO.2011.36.5908

Article  CAS  PubMed  Google Scholar 

Macdonald JS, Smalley SR, Benedetti J et al (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345(10):725–730. https://doi.org/10.1056/NEJMoa010187

Article  CAS  PubMed  Google Scholar 

Smalley SR, Benedetti JK, Haller DG et al (2012) Updated analysis of SWOG-directed Intergroup Study 0116: a Phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection. J Clin Oncol 30(19):2327–2333. https://doi.org/10.1200/JCO.2011.36.7136

Article  CAS  PubMed  PubMed Central  Google Scholar 

Park SH, Lim DH, Sohn TS et al (2021) ARTIST 2 investigators. A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial. Ann Oncol 32(3):368–374. https://doi.org/10.1016/j.annonc.2020.11.017

Article  CAS  PubMed  Google Scholar 

D’Angelica M, Gonen M, Brennan MF, Turnbull AD, Bains M, Karpeh MS (2004) Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann Surg 240(5):808–816. https://doi.org/10.1097/01.sla.0000143245.28656.15

Article  PubMed  PubMed Central  Google Scholar 

Son T, Sun J, Choi S et al (2019) Multi-institutional validation of the 8th AJCC TNM staging system for gastric cancer: analysis of survival data from high-volume eastern centers and the SEER database. J Surg Oncol 120(4):676–684. https://doi.org/10.1002/jso.25639

Article  PubMed  Google Scholar 

In H, Solsky I, Palis B, Langdon-Embry M, Ajani J, Sano T (2017) Validation of the 8th edition of the AJCC TNM staging system for gastric cancer using the national cancer database. Ann Surg Oncol 24(12):3683–3691. https://doi.org/10.1245/s10434-017-6078-x

Article  PubMed  Google Scholar 

Jiang Y, Liu W, Li T et al (2017) Prognostic and predictive value of p21-activated kinase 6 associated support vector machine classifier in gastric cancer treated by 5-fluorouracil/oxaliplatin chemotherapy. EBioMedicine 22:78–88. https://doi.org/10.1016/j.ebiom.2017.06.028

Article  PubMed  PubMed Central  Google Scholar 

Jiang Y, Xie J, Han Z et al (2018) Immunomarker support vector machine classifier for prediction of gastric cancer survival and adjuvant chemotherapeutic benefit. Clin Cancer Res 24(22):5574–5584. https://doi.org/10.1158/1078-0432.CCR-18-0848

Article  CAS  PubMed  Google Scholar 

Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: images are more than pictures, they are data. Radiology 278(2):563–577. https://doi.org/10.1148/radiol.2015151169

Article  PubMed  Google Scholar 

Aerts HJ, Velazquez ER, Leijenaar RT et al (2014) Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 5:4006. https://doi.org/10.1038/ncomms5006

Article  CAS  PubMed  Google Scholar 

Jiang Y, Chen C, Xie J et al (2018) Radiomics signature of computed tomography imaging for prediction of survival and chemotherapeutic benefits in gastric cancer. EBioMedicine 36:171–182. https://doi.org/10.1016/j.ebiom.2018.09.007

Article  PubMed  PubMed Central  Google Scholar 

Sun KY, Hu HT, Chen SL et al (2020) CT-based radiomics scores predict response to neoadjuvant chemotherapy and survival in patients with gastric cancer. BMC Cancer 20(1):468. https://doi.org/10.1186/s12885-020-06970-7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee JA, Ahn YC, Lim DH, Park HC, Asranbaeva MS (2015) Dosimetric and clinical influence of 3D versus 2D planning in postoperative radiation therapy for gastric cancer. Cancer Res Treat 47(4):727–737. https://doi.org/10.4143/crt.2014.018

Article  CAS  PubMed  Google Scholar 

Nioche C, Orlhac F, Boughdad S et al (2018) LIFEx: a freeware for radiomic feature calculation in multimodality imaging to accelerate advances in the characterization of tumor heterogeneity. Cancer Res 78(16):4786–4789. https://doi.org/10.1158/0008-5472.CAN-18-0125

Article  CAS  PubMed  Google Scholar 

van Griethuysen JJM, Fedorov A, Parmar C et al (2017) Computational radiomics system to decode the radiographic phenotype. Cancer Res 77(21):e104–e107. https://doi.org/10.1158/0008-5472.CAN-17-0339

Article  CAS  PubMed  PubMed Central  Google Scholar 

Utazirubanda JC, Leon T, Ngom P (2021) Variable selection with group LASSO approach: application to Cox regression with frailty model. Commun Stat Simul Comput 50(3):881–901. https://doi.org/10.1080/03610918.2019.1571605

Article  PubMed  Google Scholar 

Honda T, Hardle WK (2014) Variable selection in Cox regression models with varying coefficients. J Stat Plan Inference 148:67–81. https://doi.org/10.1016/j.jspi.2013.12.002

Article  Google Scholar 

Camp RL, Dolled-Filhart M, Rimm DL (2004) X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res 10(21):7252–7259. https://doi.org/10.1158/1078-0432.CCR-04-0713

Article  CAS  PubMed  Google Scholar 

Hao D, Li Q, Feng QX et al (2022) Identifying prognostic markers from clinical, radiomics, and deep learning imaging features for gastric cancer survival prediction. Front Oncol 11:725889. https://doi.org/10.3389/fonc.2021.725889

Article  PubMed  PubMed Central  Google Scholar 

Lee J, Lim DH, Kim S et al (2011) Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST Trial. J Clin Oncol 29:269–273. https://doi.org/10.1200/JCO.2011.39.1953

Article  CAS  Google Scholar 

Park SH, Sohn TS, Lee J et al (2015) Phase III trial to compare adjuvant chemotherapy with capecitabine and cisplatin versus concurrent chemoradiotherapy in gastric cancer: final report of the adjuvant chemoradiotherapy in stomach tumors trial, including survival and subset analysis. J Clin Oncol 33:3130–3136. https://doi.org/10.1200/JCO.2014.58.3930

Article  CAS  PubMed  Google Scholar 

Zheng H, Zheng Q, Jiang M et al (2022) Contrast-enhanced CT based radiomics in the preoperative prediction of perineural invasion for patients with gastric cancer. Eur J Radiol 154:110393. https://doi.org/10.1016/j.ejrad.2022.110393

Article  PubMed  Google Scholar 

Hyung WJ, Lee JH, Choi SH, Min JS, Noh SH (2002) Prognostic impact of lymphatic and/or blood vessel invasion in patients with node-negative advanced gastric cancer. Ann Surg Oncol 9(6):562–567. https://doi.org/10.1007/BF02573892

Article  PubMed  Google Scholar